Naya, Ian http://orcid.org/0000-0002-2263-1407
Tombs, Lee
Lipson, David A.
Boucot, Isabelle
Compton, Chris
Funding for this research was provided by:
GSK (Study: 209304; NCT01313637/NCT01313650)
Article History
Received: 30 November 2018
Accepted: 18 March 2019
First Online: 26 March 2019
Ethics approval and consent to participate
: All clinical studies included in this pooled analysis were carried out according to the principles of the Declaration of Helsinki and received appropriate ethical approval. Informed consent was obtained for all individual participants included in the studies used as the basis for this pooled analysis.
: Not applicable.
: IN, DAL, IB, and CC are employees of GSK and hold stocks and shares in GSK. LT is a contingent worker on assignment at GSK. ELLIPTA is owned by/licensed to the GlaxoSmithKline group of companies.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.